Aniracetam, a substance that improves cognitive function, has been discovered to specifically raise the levels of dopamine and serotonin in certain areas of the brain, such as the prefrontal cortex, basolateral amygdala, and dorsal hippocampus. This effect is observed in stroke-prone spontaneously hypertensive rats within the mesocorticolimbic system.